These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 37979169)

  • 21. Immune Escape Associated with RBD Omicron Mutations and SARS-CoV-2 Evolution Dynamics.
    Kudriavtsev AV; Vakhrusheva AV; Novosеletsky VN; Bozdaganyan ME; Shaitan KV; Kirpichnikov MP; Sokolova OS
    Viruses; 2022 Jul; 14(8):. PubMed ID: 35893668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spike protein-independent attenuation of SARS-CoV-2 Omicron variant in laboratory mice.
    Liu S; Selvaraj P; Sangare K; Luan B; Wang TT
    Cell Rep; 2022 Sep; 40(11):111359. PubMed ID: 36075211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural evolution of SARS-CoV-2 omicron in human receptor recognition.
    Zhang W; Shi K; Geng Q; Herbst M; Wang M; Huang L; Bu F; Liu B; Aihara H; Li F
    J Virol; 2023 Aug; 97(8):e0082223. PubMed ID: 37578233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The humoral and cellular immune evasion of SARS-CoV-2 Omicron and sub-lineages.
    Xiang T; Wang J; Zheng X
    Virol Sin; 2022 Dec; 37(6):786-795. PubMed ID: 36427646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spike protein of SARS-CoV-2 Omicron variant: An
    Jimenez Ruiz JA; Lopez Ramirez C; Lopez-Campos JL
    Front Public Health; 2022; 10():1052241. PubMed ID: 36523581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2 Omicron Variant of Concern: Everything You Wanted to Know about Omicron but Were Afraid to Ask.
    Shin DH; Smith DM; Choi JY
    Yonsei Med J; 2022 Nov; 63(11):977-983. PubMed ID: 36303305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS-CoV-2 Omicron XBB subvariants exhibit enhanced fusogenicity and substantial immune evasion in elderly population, but high sensitivity to pan-coronavirus fusion inhibitors.
    Xia S; Jiao F; Wang L; Yu X; Lu T; Fu Y; Huang Z; Li X; Huang J; Wang Q; Man Q; Xiong L; Jiang S; Lu L
    J Med Virol; 2023 Mar; 95(3):e28641. PubMed ID: 36890632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evolution of the SARS-CoV-2 Omicron Variants: Genetic Impact on Viral Fitness.
    Liu W; Huang Z; Xiao J; Wu Y; Xia N; Yuan Q
    Viruses; 2024 Jan; 16(2):. PubMed ID: 38399960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cryo-EM structure of a SARS-CoV-2 omicron spike protein ectodomain.
    Ye G; Liu B; Li F
    Nat Commun; 2022 Mar; 13(1):1214. PubMed ID: 35241675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile.
    Alkhatib M; Salpini R; Carioti L; Ambrosio FA; D'Anna S; Duca L; Costa G; Bellocchi MC; Piermatteo L; Artese A; Santoro MM; Alcaro S; Svicher V; Ceccherini-Silberstein F
    Microbiol Spectr; 2022 Apr; 10(2):e0273221. PubMed ID: 35352942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A bias of Asparagine to Lysine mutations in SARS-CoV-2 outside the receptor binding domain affects protein flexibility.
    Boer JC; Pan Q; Holien JK; Nguyen TB; Ascher DB; Plebanski M
    Front Immunol; 2022; 13():954435. PubMed ID: 36569921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural Plasticity and Immune Evasion of SARS-CoV-2 Spike Variants.
    Ghimire D; Han Y; Lu M
    Viruses; 2022 Jun; 14(6):. PubMed ID: 35746726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Baseline Sequencing Surveillance of Public Clinical Testing, Hospitals, and Community Wastewater Reveals Rapid Emergence of SARS-CoV-2 Omicron Variant of Concern in Arizona, USA.
    Smith MF; Holland SC; Lee MB; Hu JC; Pham NC; Sullins RA; Holland LA; Mu T; Thomas AW; Fitch R; Driver EM; Halden RU; Villegas-Gold M; Sanders S; Krauss JL; Nordstrom L; Mulrow M; White M; Murugan V; Lim ES
    mBio; 2023 Feb; 14(1):e0310122. PubMed ID: 36622143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Omicron variant evolution on vaccines and monoclonal antibodies.
    Sabbatucci M; Vitiello A; Clemente S; Zovi A; Boccellino M; Ferrara F; Cimmino C; Langella R; Ponzo A; Stefanelli P; Rezza G
    Inflammopharmacology; 2023 Aug; 31(4):1779-1788. PubMed ID: 37204696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epistasis at the SARS-CoV-2 Receptor-Binding Domain Interface and the Propitiously Boring Implications for Vaccine Escape.
    Rochman ND; Faure G; Wolf YI; Freddolino PL; Zhang F; Koonin EV
    mBio; 2022 Apr; 13(2):e0013522. PubMed ID: 35289643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spike mutations contributing to the altered entry preference of SARS-CoV-2 omicron BA.1 and BA.2.
    Hu B; Chan JF; Liu H; Liu Y; Chai Y; Shi J; Shuai H; Hou Y; Huang X; Yuen TT; Yoon C; Zhu T; Zhang J; Li W; Zhang AJ; Zhou J; Yuan S; Zhang BZ; Yuen KY; Chu H
    Emerg Microbes Infect; 2022 Dec; 11(1):2275-2287. PubMed ID: 36039901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants.
    Reuschl AK; Thorne LG; Whelan MVX; Ragazzini R; Furnon W; Cowton VM; De Lorenzo G; Mesner D; Turner JLE; Dowgier G; Bogoda N; Bonfanti P; Palmarini M; Patel AH; Jolly C; Towers GJ
    Nat Microbiol; 2024 Feb; 9(2):451-463. PubMed ID: 38228858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intranasal Boosting with Spike Fc-RBD of Wild-Type SARS-CoV-2 Induces Neutralizing Antibodies against Omicron Subvariants and Reduces Viral Load in the Nasal Turbinate of Mice.
    Cai JP; Luo C; Wang K; Cao H; Chen LL; Zhang X; Han Y; Yin F; Zhang AJ; Chu H; Yuan S; Kok KH; To KK; Chen H; Chen Z; Jin DY; Yuen KY; Chan JF
    Viruses; 2023 Mar; 15(3):. PubMed ID: 36992395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SARS-CoV-2 Omicron Variant in Medicinal Chemistry Research.
    Souza Rocha W; Zhan P; Ferreira da Silva-Júnior E
    Curr Top Med Chem; 2023; 23(17):1625-1639. PubMed ID: 37055893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody evasion associated with the RBD significant mutations in several emerging SARS-CoV-2 variants and its subvariants.
    Bhattacharya M; Chatterjee S; Lee SS; Dhama K; Chakraborty C
    Drug Resist Updat; 2023 Nov; 71():101008. PubMed ID: 37757651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.